Department of Vascular Medicine.
Department of Surgical Oncology and Endocrine Surgery.
J Hypertens. 2018 Jul;36(7):1585-1591. doi: 10.1097/HJH.0000000000001718.
The aldosterone-to-renin ratio is widely used and is the recommended screening modality for primary aldosteronism by the Endocrine Society Guideline. However, studies on its diagnostic accuracy have been inconsistent, which is mainly because of methodological limitations. We set out to evaluate this diagnostic value by using a highly standardized study protocol, which is in line with the Endocrine Society Guideline recommendations regarding indications for screening, testing conditions and reference standards in daily clinical practice.
In this prospective study, 233 consecutive patients referred to the University Medical Center Utrecht with difficult-to-control hypertension were enrolled. In addition to aldosterone-to-renin ratio measurements, all patients underwent a saline infusion test as a reference standard. A plasma aldosterone concentration greater than 280 pmol/l after saline infusion was considered diagnostic for aldosteronism and the plasma renin activity was assessed to exclude patients with secondary aldosteronism from the final primary aldosteronism diagnosis.
Correlation of the aldosterone-to-renin ratio (cut-off >5) with primary aldosteronism diagnosis showed 16 true positive, 29 false positive, 188 true negative and 0 false negative aldosterone-to-renin ratios, resulting in a sensitivity of 100% (CI 75.9-100), specificity of 86.7% (CI 81.2-90.7), positive-predictive value of 35.6% (CI 22.3-51.3) and negative-predictive value of 100% (CI 97.5-100.0). The corresponding area under the curve was 0.933 (CI 0.900-0.966).
These findings show that the aldosterone-to-renin ratio is a good screening modality for primary aldosteronism and is without a high risk of missing a primary aldosteronism diagnosis whenever performed under well standardized conditions.
醛固酮与肾素比值在临床上被广泛应用,也是内分泌学会指南推荐用于原发性醛固酮增多症筛查的首选方法。然而,关于其诊断准确性的研究结果并不一致,这主要是由于方法学上的局限性。我们旨在通过使用高度标准化的研究方案来评估这种诊断价值,该方案符合内分泌学会指南关于在日常临床实践中筛查的适应证、检测条件和参考标准的建议。
在这项前瞻性研究中,我们纳入了 233 例因难治性高血压而被转诊至乌得勒支大学医学中心的连续患者。除了醛固酮与肾素比值的测量外,所有患者还进行了盐水输注试验作为参考标准。盐水输注后血浆醛固酮浓度大于 280 pmol/l 被认为是醛固酮增多症的诊断标准,并评估血浆肾素活性以排除继发性醛固酮增多症患者,从而得出最终的原发性醛固酮增多症诊断。
用醛固酮与肾素比值(临界值>5)来诊断原发性醛固酮增多症,结果显示 16 个比值为真阳性,29 个比值为假阳性,188 个比值为真阴性,0 个比值为假阴性,其诊断原发性醛固酮增多症的敏感性为 100%(95%置信区间为 75.9-100),特异性为 86.7%(95%置信区间为 81.2-90.7),阳性预测值为 35.6%(95%置信区间为 22.3-51.3),阴性预测值为 100%(95%置信区间为 97.5-100.0)。相应的曲线下面积为 0.933(95%置信区间为 0.900-0.966)。
这些发现表明,醛固酮与肾素比值是一种很好的原发性醛固酮增多症筛查方法,只要在标准化条件下进行,就不会错过原发性醛固酮增多症的诊断。